Close
Nordic 9Nordic 9

Nanoform Finland (private company)

Finland nanoform.fi
See something wrong or missing? Let us know
Offices:Helsinki
Industry:BiotechHealth servicesPharma
Business model:B2B

Nanoform Finland Ltd has developed a proprietary technology called Controlled Expansion of Supercritical Solutions (CESS) that allows nanonization of drug particles. Implementing CESS offers new technological and business advantages for the pharmaceutical industry.

Investors: we tracked 3 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 19.27M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Nanoform Finland

Name Criteria
Sweden Cinclus Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Spain Oncomatryx
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
France Owkin
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Switzerland Pharvaris
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Spain Sanifit Therapeutics
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark STipe Therapeutics
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
United Kingdom Exiscientia
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark Cytoki Pharma
60%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top